| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.018 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |